-
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and hydroxychloroquine used for...
25 March 2021
-
Updated review: Can international travel-related control measures contain the spread of the COVID-19 pandemic?
What are international travel-related control measures?
International travel control measures are methods to manage international travel to contain the spread of COVID-19. Measures include:
closing international borders to stop...
25 March 2021
-
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19.
Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment.
Studies of other...
18 March 2021
-
17 March 2021
-
15 March 2021
-
15 March 2021
-
15 March 2021
-
11 March 2021
-
In this short interview, Prof. John GF Cleland, senior author of this recently published Cochrane review, tells us about what this review found regarding the type of heart and blood vessel problems that complicate COVID-19 infections.
Tell us about this review.
This review first focuses on cardiovascular problems pre-existing the development of...
11 March 2021
-
Evidence published in the Cochrane Library today will reassure people who want to stop smoking that quitting for at least 6 weeks may improve their mental wellbeing, by reducing anxiety, depression, and stress. People’s social relationships are unlikely to suffer if they stop smoking.
Smoking is the world's leading cause of preventable illness...
9 March 2021
COVID-19 is an infectious respiratory disease caused by a coronavirus called SARS-CoV-2. If the infection becomes severe, people may need intensive care and support in hospital, including mechanical ventilation.Drugs used for other diseases were tried out in COVID-19, and this included chloroquine, used for malaria; and hydroxychloroquine used for...25 March 2021
Updated review: Can international travel-related control measures contain the spread of the COVID-19 pandemic? What are international travel-related control measures? International travel control measures are methods to manage international travel to contain the spread of COVID-19. Measures include: closing international borders to stop...25 March 2021
This recently published Cochrane review examines the effects of a class of treatments on people with COVID-19. Treating COVID-19 with tocilizumab (a medicine that blocks interleukin-6) reduces the numbers of people who die within 28 days of treatment, and probably results in fewer serious unwanted effects than placebo treatment. Studies of other...18 March 2021
17 March 2021
15 March 2021
15 March 2021
15 March 2021
11 March 2021
In this short interview, Prof. John GF Cleland, senior author of this recently published Cochrane review, tells us about what this review found regarding the type of heart and blood vessel problems that complicate COVID-19 infections. Tell us about this review. This review first focuses on cardiovascular problems pre-existing the development of...11 March 2021
Evidence published in the Cochrane Library today will reassure people who want to stop smoking that quitting for at least 6 weeks may improve their mental wellbeing, by reducing anxiety, depression, and stress. People’s social relationships are unlikely to suffer if they stop smoking. Smoking is the world's leading cause of preventable illness...9 March 2021